Updated ACIP immunization schedule released for adults

Updated ACIP immunization schedule released for adults
(HealthDay)—The Advisory Committee on Immunization Practices has released its updated adult immunization schedule for 2019; the schedule was published online Feb. 5 in the Annals of Internal Medicine.

David K. Kim, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and Paul Hunter, M.D., from the University of Wisconsin in Madison, provide immunization recommendations for adults aged 19 years and older.

The authors describe changes to the 2019 adult immunization schedule. These changes include updated recommendations on the use of live attenuated ; for the 2018 to 2019 season, any licensed influenza vaccine that is age and health-status appropriate may be used. The new single-antigen recombinant hepatitis B vaccine (Heplisav-B) is recommended for prevention of hepatitis B virus infection. It is routinely administered in two doses at least four weeks apart. The vaccine is not recommended for pregnant women as no safety data are available on its use during pregnancy. Homelessness has been added as an indication for routine hepatitis A vaccination in addition to other populations at high risk who should receive routine vaccination.

"By consistently using the Recommended Adult Immunization Schedule, United States, 2019, and implementing the standards for adult immunization practice, can reduce the burden of illnesses, hospitalizations, and mortality associated with vaccine-preventable diseases among their adult patients," the authors write.


Explore further

AAP updates recommendations for pediatric flu vaccination

More information: Abstract/Full Text
Journal information: Annals of Internal Medicine

Copyright © 2019 HealthDay. All rights reserved.

Citation: Updated ACIP immunization schedule released for adults (2019, February 5) retrieved 24 May 2019 from https://medicalxpress.com/news/2019-02-acip-immunization-adults.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more